Frovatriptan use while Breastfeeding
Drugs containing Frovatriptan: Frova
Frovatriptan Levels and Effects while Breastfeeding
Summary of Use during Lactation
No published experience exists with frovatriptan during breastfeeding. If frovatriptan is required by the mother, it is not a reason to discontinue breastfeeding. However, because frovatriptan has a long half-life of 25 to 30 hours, a shorter-acting alternate drug may be preferred, especially while nursing a newborn or preterm infant.[1]
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
References
1. Amundsen S, Nordeng H, Nezvalova-Henriksen K et al. Pharmacological treatment of migraine during pregnancy and breastfeeding. Nat Rev Neurol. 2015;11:209-19. PMID: 25776823
Frovatriptan Identification
Substance Name
Frovatriptan
CAS Registry Number
158747-02-5
Drug Class
Serotonin Agonists
Administrative Information
LactMed Record Number
577
Last Revision Date
20150908
Disclaimer
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.
